1Furuse K,Fukuoka M,Kawahara M,et al.Phase Ⅲ study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin,vinblastine and cisplatine in unresectable stage Ⅲ non-small cell lung cancer[J].J Clin Oncol,1999,17:2692-2699.
2Curran W,Scott C,Langer C,et al.Phase Ⅲ comparison of sequential vs.concurrent chemoradiation of pts with unresected stage Ⅲ non-small cell lung cancer (NSCLC):initial report of Radiation Therapy Oncology Group (RTOG) 9410[C].Proc.Am Soc Clin Oncol,2000,Abstract 1891.
3Albain K,Rusch VW,Crowley JJ,et al.Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stage ⅢA (N2) and ⅢB non-small cell lung cancer:mature results of Southwest Oncology Group phase Ⅱ study 8805[J].J Clin Oncol,1995,13:1880-1892.
4Albain KS,Scott CB,Rusch VR,et al.Phase Ⅲ comparision of concurrent chemotherapy plus radiotherapy (CT/RT) and CT/RT followed by surgical resection for stage ⅢA(PN2) non-small cell lung cancer (NSCLC):Initial results from intergroup trial 0139(RTOC 93-09)[C].Proc Am Soc Clin Oncol,2003,Abstract 2497.
6Vokes EE,Derndon JE,Kelly MJ,et al.Induction chemotherapy followed by concurrent chemoradiotherapy(CT/XRT) versus CT/XRT alone for regionally advanced unresectable non-small cell cancer:Initial analysis of a randomized phase 3 trial[C].Proc Am Soc Clin Oncol,2004,Abstract 7005.
7Huber RM,Flentje M,Gosse H,et al.Induction chemotherapy and following simultaneous radiochemotherapy versus induction chemotherapy and radiotherapy alone in inoperable NSCLC(stage ⅢA/ⅢB):Update of CT/RT 99/97[C].Proc Am Soc Clin Oncol,2004,Abstract 7075.
8Cater DL,Keller AM,Tolley RC,et al.A randomized phase Ⅲ trial of combined paclitaxel,carboplatin,and radiation therapy folled by either weekly paclitaxel observation in patients with stage Ⅲ non-small cell lung cancer[C].Proc Am Soc Clin Oncol,2004,Abstract 7076.
9Kelly K,Gaspar LE,Chansky K et al.Low incidence of pneumonitis on SWOG 0023:A preliminary analysis of an onging phase 3 trial of concurrent chemoradiotherapy followed by consolidation docetaxel and gefitinib/placebo maintenance in patients with inoperable stage 3 non-small cell lung cancer[C].Proc Am Soc Clin Oncol,2005,Abstract 7058.
10Gandara DR,Chansky K,Gaspar LE,et al.Long term survival in stage 3b non-small cell lung cancer (NSCLC) treatment with consolidation docetaxel following concurrent chemoradiotherapy (SWOGS 9504)[C].Proc Am Soc Clin Oncol,2005,Abstract 7059.